|
|
TZ12H130
|
Insugen 30/70
|
Dibasic Sodium Phosphate g/10ml,Glycerin g/10ml,Hydrochloric acid g/10ml,Insulin (Human of recombinant DNA origin) 100 g/10ml,Liquified Phenol g/10ml,Metacresol g/10ml,Protamine Sulphate g/10ml,Sodium Hydroxide g/10ml,Water for Injection g/10ml,Zinc g/10ml
|
Biocon Biologics Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 23 V 0616
|
KRABEVA 100mg/4ml
|
Alpha, alpha trehalose dihydate 240 mg/vial,Bevacizumab 100 mg/4ml,Polysorbate 20 1.6 mg/vial,Sodium Dihydrogen Phosphate Dihyrate 23.2 mg/vial,Sodium Phosphate dibasic anhydrous 4.8 mg/vial,Water for injection USP 4 ml
|
BIOCON BIOLOGICS LIMITED
|
Registered/Compliant
|
Details →
|
|
|
TAN 23 HM 0617
|
KRABEVA 400mg/16mL
|
Bevacizumab 400 mg/16ml,Polysorbate 20 6.4 mg/6 mL,Sodium Dihydrogen Phosphate Dihyrate 92.8 mg/6 mL,Sodium Phosphate dibasic anhydrous 19.2 mg/6 mL,Water for injection USP 16 ml,α, α - Trehalose dihydrate 960 mg/6 mL
|
BIOCON BIOLOGICS LIMITED
|
Registered/Compliant
|
Details →
|
|
|
TZ12H129
|
Insugen N
|
Insulin (Human of recombinant DNA origin) 100 g/10ml
|
Biocon Biologics Limited
|
Registered/Compliant
|
Details →
|
|
|
TZ12H233
|
Insugen 30/70 Cartridge
|
Insulin Human (Recombinant) 100 IU/ml
|
Biocon Biologics Limited
|
Registered/Compliant
|
Details →
|
|
|
TZ12H098
|
Insugen R
|
Human Insulin 100 g/10ml
|
Biocon Biologics Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 20 HM 0098
|
canhera
|
Trastuzumab 150 mg/vial
|
Biocon Biologics Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 21 HM 0384
|
canhera
|
Trastuzumab 440 mg/vial
|
Biocon Biologics Limited
|
Registered/Compliant
|
Details →
|